HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beiersdorf

This article was originally published in The Rose Sheet

Executive Summary

Hamburg, Germany-based marketer of Eucerin, Nivea and La Prairie skin-care lines reported a 38% drop in earnings to €380 mil., or $517 mil., for fiscal 2009. Sales in its consumer segment totaled roughly €5 bil., or $6.8 bil., a 2.2% decline from prior year, with currency fluctuations. Eucerin led the way for Beiersdorf's lines, with 6.5% global growth. Nivea posted gain of 1.3%, while firm's luxury La Prairie franchise experienced an 8.7% decline. Sales in the firm's consumer segment rose 13.3% in Latin America for the year. In a March 4 release, Chairman Thomas-B. Quass suggested firm is well-positioned for new market reality following the economic crisis, but noted it will "need to be even more flexible and focus even more strongly on [its] core competencies in the future.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016769

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel